Table 6 of Yadav, Mol Vis 2026; 32:388-408.


Table 6. Serum VEGF-A and CRP Levels in control, AMD patients and AMD subtypes.

  Crude analysis Analysis adjusted for age and smoking
Group Count Mean (pg/ml) SD (pg/ml) p-value Mean (pg/ml) SEM (pg/ml) p-value
VEGFA levels
Control 100 19.89 13.25 <0.0001 20.52 2.47 <0.001
AMD patients 160 46.25 28.37 45.86 1.92
 
Control 100 19.89 13.247 <0.0001 20.52 2.47 <0.001
Dry AMD patients 50 38.89 25.16 38.64 3.33
 
Control 100 19.89 13.25 <0.0001 20.48 2.44 <0.001
Wet AMD patients 110 49.49 29.18 49.18 2.28
 
Dry AMD 50 38.89 25.1575 0.049 38.64 3.33 0.027
Wet AMD patients 110 49.49 29.19 49.18 2.28
 
CRP levels
Control 100 2008.52 1010.25 <0.001 2018.54 103.46 <0.001
AMD Patient 160 2500.85 977.19 2494.60 80.58
 
Control 100 2008.52 1010.25 <0.01 2018.54 103.46 0.005
Dry AMD 50 2591.59 1073.40 2586.99 141.41
 
Control 100 2008.52 1010.25 <0.01 2018.54 103.46 0.010
Wet AMD 110 2459.60 932.46 2452.10 96.73
 
Dry AMD 50 2591.59 1073.40 0.21 2586.99 141.41 1.00
Wet AMD 110 2459.60 932.46 2452.10 96.73